Scarica l'app Stockscreener
32.61
0.91%
-0.27
Precedente Chiudi:
$32.88
Aprire:
$33.02
Volume 24 ore:
191.67K
Relative Volume:
0.50
Capitalizzazione di mercato:
$1.03B
Reddito:
$566.77M
Utile/perdita netta:
$48.16M
Rapporto P/E:
27.40
EPS:
1.19
Flusso di cassa netto:
$274.29M
1 W Prestazione:
-1.90%
1M Prestazione:
-8.53%
6M Prestazione:
+20.58%
1 anno Prestazione:
-17.18%
Intervallo 1D:
$32.43
$33.55
Intervallo di 1 settimana:
$31.26
$33.55
Portata 52W:
$23.23
$39.95
Collegium Pharmaceutical Inc Stock (COLL) Company Profile
Nome
Collegium Pharmaceutical Inc
Settore
Telefono
781-713-3699
Indirizzo
100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA
Confronta COLL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
COLL
Collegium Pharmaceutical Inc
|
32.59 | 1.01B | 566.77M | 48.16M | 274.29M | 1.19 |
|
ZTS
Zoetis Inc
|
143.65 | 63.58B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.92 | 43.58B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.205 | 40.83B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
19.77 | 23.07B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
430.10 | 19.61B | 3.08B | 1.24B | 1.07B | 25.61 |
Collegium Pharmaceutical Inc Stock (COLL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-10 | Aggiornamento | Needham | Hold → Buy |
| 2024-07-30 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2024-06-07 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-05-10 | Downgrade | Needham | Buy → Hold |
| 2024-05-10 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-01-04 | Downgrade | Jefferies | Buy → Hold |
| 2023-08-25 | Reiterato | Needham | Buy |
| 2023-05-02 | Ripresa | Jefferies | Buy |
| 2022-08-08 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2022-02-15 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2021-08-06 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2021-01-11 | Reiterato | H.C. Wainwright | Buy |
| 2020-07-14 | Iniziato | BWS Financial | Sell |
| 2020-05-27 | Iniziato | Guggenheim | Neutral |
| 2020-02-19 | Ripresa | Jefferies | Buy |
| 2019-10-30 | Reiterato | Needham | Buy |
| 2019-05-03 | Ripresa | H.C. Wainwright | Buy |
| 2019-04-12 | Ripresa | Janney | Buy |
| 2019-03-20 | Iniziato | SunTrust | Hold |
| 2019-01-16 | Reiterato | Needham | Buy |
| 2018-03-08 | Reiterato | H.C. Wainwright | Buy |
| 2018-02-07 | Reiterato | Needham | Buy |
| 2017-12-05 | Reiterato | Needham | Buy |
| 2017-09-11 | Iniziato | H.C. Wainwright | Buy |
| 2017-05-11 | Reiterato | Needham | Buy |
| 2016-09-13 | Iniziato | Gabelli & Co | Buy |
| 2015-06-01 | Iniziato | Jefferies | Buy |
| 2015-06-01 | Iniziato | Needham | Buy |
| 2015-06-01 | Iniziato | Piper Jaffray | Overweight |
Mostra tutto
Collegium Pharmaceutical Inc Borsa (COLL) Ultime notizie
How Collegium Pharmaceutical Inc. stock performs in rate cut cyclesBear Alert & Risk Adjusted Buy/Sell Alerts - newser.com
Will Collegium Pharmaceutical Inc. (354) stock sustain dividend payoutsM&A Rumor & High Conviction Trade Alerts - newser.com
Collegium Pharmaceutical Inc. Rings the Opening Bell - Nasdaq
Collegium to Celebrate 10-Year Anniversary with Nasdaq Opening Bell Ringing - Sahm
Strategies to average down on Collegium Pharmaceutical Inc.July 2025 Fed Impact & Community Shared Stock Ideas - newser.com
How Collegium Pharmaceutical Inc. (354) stock compares with tech leadersPortfolio Value Summary & Weekly Market Pulse Updates - newser.com
Will Collegium Pharmaceutical Inc. stock gain from strong economy2025 Major Catalysts & Pattern Based Trade Signal System - newser.com
Applying sector rotation models to Collegium Pharmaceutical Inc.IPO Watch & Daily Profit Maximizing Tips - newser.com
Why retail investors pile into Collegium Pharmaceutical Inc. stock2025 Market Outlook & Momentum Based Trading Signals - newser.com
Is Collegium Pharmaceutical Inc. stock a top pick in earnings seasonWeekly Market Report & Low Risk Entry Point Guides - newser.com
How interest rate cuts could boost Collegium Pharmaceutical Inc. stockGlobal Markets & High Accuracy Buy Signal Tips - newser.com
10-Year Anniversary: Collegium to Ring Nasdaq Bell Oct. 14, 2025; Highlights Jornay PM ADHD growth - Stock Titan
Collegium Pharmaceutical (COLL) Q1 Earnings and Revenues Surpass Estimates - sharewise.com
Collegium Pharmaceutical Experiences Revision in Its Stock Evaluation Amidst Market Dynamics - Markets Mojo
UnitedHealth, Brookdale, Collegium Pharmaceutical, QuidelOrtho, and Biogen Shares Are Falling, What You Need To Know - Yahoo Finance
Collegium Pharmaceutical, Inc. (COLL): A Bull Case Theory - MSN
Collegium Pharmaceutical (NASDAQ:COLL) Receives "Hold (C)" Rating from Weiss Ratings - MarketBeat
Pattern recognition hints at Collegium Pharmaceutical Inc. upsideJobs Report & Free Technical Pattern Based Buy Signals - newser.com
Oversold Conditions For Collegium Pharmaceutical (COLL) - Nasdaq
Chronic Lower Back Pain Market Projected to Grow by 2034 | Eli Lilly, Collegium Pharmaceutical, Purdue Pharma, BioDelivery Sciences, Camurus, Braeburn, Scilex Holding, Mesoblast, AnGes MG, Kolon Life - Barchart.com
Can Collegium Pharmaceutical Inc. rally from current levelsPortfolio Gains Summary & Daily Price Action Insights - newser.com
Is Collegium Pharmaceutical Inc. (354) stock inflation resilientJuly 2025 Trade Ideas & Safe Swing Trade Setup Alerts - newser.com
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives $42.33 Average Price Target from Brokerages - Defense World
Will Collegium Pharmaceutical Inc. bounce back from current supportWeekly Loss Report & Verified Momentum Stock Ideas - newser.com
Historical volatility pattern of Collegium Pharmaceutical Inc. visualized2025 Market Sentiment & Free Safe Entry Trade Signal Reports - newser.com
Long term hold vs stop loss in Collegium Pharmaceutical Inc.Weekly Risk Summary & AI Powered Market Trend Analysis - newser.com
GAMMA Investing LLC Raises Stake in Collegium Pharmaceutical, Inc. $COLL - Defense World
What drives Collegium Pharmaceutical Inc 354 stock priceEarnings Per Share Trends & High Profit Market Tips - earlytimes.in
Does Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Create Value For Shareholders? - Yahoo Finance
Collegium Pharmaceutical Inc Azioni (COLL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.83%
0.45%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):